Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients?
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2026
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1867012575451938816 |
|---|---|
| author | Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren |
| author_facet | Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren |
| collection | Wiley Open Access |
| contents | Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren Journal of Clinical Apheresis ABSTRACT Microplastic particles (MP) from industrial products and degradation of plastic waste are ubiquitous in our environment and convey serious potential risks to human health. There is currently no established method for removing MP from the human body. MP circulate in the blood and have been found in the eluate plasma from double filtration plasmapheresis procedures, suggesting that plasmapheresis could be used to remove MP from the body. We have measured circulating MP in the blood of 114 patients before and after 174 1‐plasma‐volume therapeutic plasma exchange (TPE) procedures using the Spectra Optia Apheresis System and have shown that circulating MP are reduced by TPE. The reduction is obscured at low starting levels of MP because of leaching of MP back into the circulation from the plastic apheresis tubing set. Nonetheless, this is the first demonstration that it is possible to reduce circulating MP in human patients. 10.1002/jca.70135 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1002/jca.70135 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_jca_70135 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren Journal of Clinical Apheresis Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? Robert Weinstein Zehra Stara Yuksel Christina Anderson Deborah Grant Paul Milius Kerry Waldron Lou Ann David Charesse Molina Ilene S. Ruhoy David L. Kaufman Chris Renna Florence Comite Brad Younggren Journal of Clinical Apheresis ABSTRACT Microplastic particles (MP) from industrial products and degradation of plastic waste are ubiquitous in our environment and convey serious potential risks to human health. There is currently no established method for removing MP from the human body. MP circulate in the blood and have been found in the eluate plasma from double filtration plasmapheresis procedures, suggesting that plasmapheresis could be used to remove MP from the body. We have measured circulating MP in the blood of 114 patients before and after 174 1‐plasma‐volume therapeutic plasma exchange (TPE) procedures using the Spectra Optia Apheresis System and have shown that circulating MP are reduced by TPE. The reduction is obscured at low starting levels of MP because of leaching of MP back into the circulation from the plastic apheresis tubing set. Nonetheless, this is the first demonstration that it is possible to reduce circulating MP in human patients. 10.1002/jca.70135 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? |
| topic | Journal of Clinical Apheresis |
| url | https://onlinelibrary.wiley.com/doi/10.1002/jca.70135 |